Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa

G. Kelly, Rosalind Hughes, Trudy McGarry et al. · British Journal of Dermatology · 2015 · 301 citations · Full text

Medicine, Dermatology, Immunology +17

Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study

Inge E. Deckers, Farida Benhadou, Marjolein J. Koldijk et al. · Journal of the American Academy of Dermatology · 2016 · 112 citations

Veterinary Medicine, Immunology, Pathology +8

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (<scp>IL</scp>)‐17A,<scp>IL</scp>‐12/23 and<scp>CD</scp>20 in hidradenitis suppurativa: an<i>ex vivo</i>study

Allard R.J.V. Vossen, Christine B. Ardon, Hessel H. van der Zee et al. · British Journal of Dermatology · 2019 · 52 citations · Full text

Medicine, Dermatology, Immunology +17